ASCO GU24 special: Dr. Kim Chi discusses CONTACT-2 results
EAU Podcasts - Un podcast de European Association of Urology - Les dimanches
Catégories:
In this podcast interview live from ASCO GU24 in San Francisco, UROONCO PCa associate editor Dr. Constance Thibault (FR) talks to medical oncologist Dr. Kim Chi from the University of British Columbia, Canada, about the CONTACT-2 trial. This randomised phase 3 trial aimed to evaluate the efficacy of cabozantinib + atezolizumab vs. second novel hormonal therapy in patients with metastatic castration-resistant prostate cancer (mCRPC).Dr. Chi shares his interpretation of the study design and the...
